Joshua Sommerfeld
Private Equity Principal @ Wellington Management
San Francisco, United States
Joshua Sommerfeld is a Series D investor at Wellington Management in San Francisco focused on Medical and Genetics. Josh is a Private Equity Principal at Wellington Management, where he leads coverage of private market investments in the healthcare services, healthcare IT, medical devices, diagnostics, and life science tools sub-verticals.Prior Wellington, Josh was a member of the investment team at Redmile Group, where he invested in growth-stage healthcarecompanies. Josh has played a role in founding multiple digital health companies and was part of the early team at Stride Health, where he built the company’s sales, customer support, regulatory, and data operations teams. Previously, Josh was an Associate at Bain Capital Ventures, where he focused on healthcare IT and healthcare services. Josh began his career as a management consultant at Bain & Company in Chicago and Melbourne, Australia.Josh graduated with honors from University of Chicago where he received a BA in South Asian Languages and Civilizations.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Joshua Sommerfeld invests in
Stages Joshua Sommerfeld invests in
Countries Joshua Sommerfeld invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Genetics 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series D 1 (50%)
- Series F 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Capital Rx is a health technology company that engages in managing pharmacy benefit plans. The company is redefining the way prescriptions are priced and administered in the U.S. Through its Clearinghouse Model, it unlocks the pharmacy supply chain and reduces prescription costs for employer groups. By establishing a competitive marketplace fordrug pricing, Capital Rx focuses its resources on deploying actionable strategies that improve plan performance and patient outcomes. | $252M / Series F / Sep 23, 2025 | ||
| Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietaryapproach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality. | $277M / Series D / Jul 11, 2024 |
Co-Investors
About Wellington Management
Wellington Management focuses on investment management. The company applies its full resources to meet the needs of the institutional clients they serve. Their investment approaches span equity, fixed income, currency, commodity, and alternative markets. They also offer asset allocation, multi-manager, and speciality approaches.
Wellington Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alain Mandy
Managing Director & Chief Operating Officer Funds
|
|||
Jean Hynes
CEO, Managing Partner, and Portfolio Manager
|
|||
Jackson Cummings
Head of Diverse Founders Investing
|
|||
|
Joshua Sommerfeld
Private Equity Principal
|
|||
Matthew Witheiler
Private Equity
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Joshua Sommerfeld invest in?
Joshua Sommerfeld invests primarily in Medical, Genetics and Health Care startups, most often at Series D and Series F stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Joshua Sommerfeld?
Public channels for Joshua Sommerfeld include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Joshua Sommerfeld last invest?
The most recent investment recorded for Joshua Sommerfeld closed in Sep 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
